Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

NCT05064553 is registered in ClinicalTrials.gov with Exact Sciences Corporation as lead sponsor.

NCT NCT05064553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05064553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Lead sponsor
Exact Sciences Corporation
Phase
Observational
Overall status
Active, not recruiting
Start date
July 26, 2021
Completion date
December 31, 2026
Enrollment
2,990 (actual)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatitis b, hepatocellular cancer, hepatocellular carcinoma, liver cancer